Sign In
Buy VIVO
$3.90
+0.170 (+4.56%)
At Close: Aug 04, 2026
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
09:00am, Thursday, 05'th Sep 2024
FORT MILL, SC / ACCESSWIRE / September 5, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) today announced that at the recently held European Society of Cardiology (ESC) Symposium, interim results
FORT MILL, SC / ACCESSWIRE / July 16, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today that the patient follow-up phase for the VIVO
Catheter Precision, Inc. Announces Receipt of First Purchase Order for VIVO from Distributor in Middle East
08:00am, Thursday, 20'th Jun 2024
FORT MILL, SC / ACCESSWIRE / June 20, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company announced that it has received its first purcha
- OCM™ was significantly better than comparators at halting proliferation of MRSA and PA –- OCM™ recorded the lowest bacterial counts of any treatment arm –- OCM™ showed significantly faster
Medical Devices Stock Pumps Up Buy Point With New Innovations
05:15pm, Thursday, 17'th Nov 2022
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up B
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
06:25am, Friday, 07'th Oct 2022
This quartet of stocks has plenty of growth ahead and is already profitable.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
10:20am, Thursday, 15'th Sep 2022 Zacks Investment Research
Sector ETF report for XHE
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, VIVO, HNGR, CMAX
09:00am, Monday, 15'th Aug 2022
NEW YORK , Aug. 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ONEM, HNGR
12:00am, Monday, 08'th Aug 2022
NEW YORK , Aug. 8, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
Meridian Bioscience (VIVO) Meets Q3 Earnings Estimates
01:25pm, Friday, 05'th Aug 2022 Zacks Investment Research
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 0% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
09:45pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -4.76% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
10:20am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Smart Beta ETF report for XHE
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
02:00pm, Friday, 29'th Jul 2022 Zacks Investment Research
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
12:26pm, Friday, 29'th Jul 2022
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022
02:02pm, Friday, 08'th Jul 2022 Benzinga
Upgrades
According to Wedbush, the prior rating for Diebold Nixdorf Inc (NYSE:DBD) was changed from Neutral to Outperform. Diebold Nixdorf earned $1.61 in the first quarter, compared to $0.29 in the
